Caris Life Sciences, Inc. logo
CAI

Caris Life Sciences, Inc.

Last Price US$16.99 Latest stored quote
Market Cap US$4.8b Company size context
7D Performance -7.16% Past 7 days
1Y Performance -36.18% Past 12 months
Model Rating Not rated Insufficient reported history for the model
Loading Mave Thesis research outlook

Dashboard Funda..tals Prediction Screener Map

Caris Life Sciences, Inc. Overview

Industry: Medical Specialities

Sector: Health Care

Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Genome, Whole Exome and Whole Transcriptome Sequencing), advanced AI and machine learning, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies and high-performance computing provides a differentiated platform for developing the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development. Caris was founded with a vision to realize the potential of precision medicine to improve the human condition. Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Genome, Whole Exome and Whole Transcrip Read More

Newly listed company coverage

Verified company profile, price history, and SEC registration source are available.

10-Q/10-K financial data, or the foreign-issuer equivalent, is not available yet.

Review the SEC registration filing

Reported Results

No latest earnings report cached yet

Run the EDGAR earnings refresh to load the latest company-filed earnings release, 10-Q, 10-K, or transcript exhibit for this ticker.

Recent News



Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

Annual 10-K/20-F financial statement data is not available yet.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Caris Life Sciences, Inc. logo

Caris Life Sciences, Inc.

US$16.99

US$4.8b

-7.16%

-36.18%